Latest news with #Mannatech
Business Wire
11 hours ago
- Business
- Business Wire
Mannatech Announces Promotion of Peter Griscom to Chief Operating Officer
FLOWER MOUND, Texas--(BUSINESS WIRE)-- Mannatech, Incorporated (NASDAQ: MTEX) announces the promotion of Peter Griscom to Chief Operating Officer of Mannatech Incorporated (the "Company") effective July 1, 2025. Peter Griscom brings more than 10 years of experience in the direct selling channel and has extensive experience in working in the consumer goods space, including launching, leading, and restructuring companies while creating efficiencies in manufacturing, sales, and marketing. Prior to his promotion, Mr. Griscom served as the Company's senior vice president of global operations since August 21, 2024 and prior to that served as the senior vice president of product, innovation, & supply chain from July 3, 2023 through August 20, 2024. He holds a B.S. from the University of Auburn and an M.S. from the University of Utah. Commenting on Mr. Griscom's promotion, Landen Fredrick, the Company's President and CEO stated, 'Peter's drive and determination to create operational efficiencies and streamline processes are instrumental in reducing costs and moving the Company forward. Elevating Peter to this new role will have a positive impact on the Company's future.' About Mannatech: Mannatech is a leading global health and wellness company committed to empowering everyone to live their best life through cutting-edge, science-backed nutritional products, patented technology, and a rewarding business opportunity. With operations in more than 25 markets †, Mannatech helps people to live healthier, more fulfilling lives while making a positive social impact in the world. Individuals interested in Mannatech's products or in exploring its business opportunity can learn more at Please Note: This release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as 'may,' 'will,' 'should,' "hope," 'could,' 'would,' 'expects,' 'plans,' 'intends,' 'anticipates,' 'believes,' 'estimates,' 'approximates,' 'predicts,' 'projects,' 'potential,' and 'continues' or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the impact of COVID-19 on Mannatech's business, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Business Wire
05-06-2025
- Business
- Business Wire
Mannatech Announces Results of Annual Shareholders' Meeting
FLOWER MOUND, Texas--(BUSINESS WIRE)-- Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 3, 2025. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting, and James Clavijo, Mannatech's Chief Financial Officer, spoke to the shareholders sharing the company's financial results for 2024. There were 1,900,930 outstanding shares of Mannatech's common stock as of April 8, 2025 entitled to vote and 1,478,342 shares, or approximately 77.8% represented at the Meeting, either in person or by proxy. The following matters were submitted and voted upon at the Meeting: 1. Mannatech shareholders voted on the election of two individuals to the Board of Directors as Class II Directors to hold office until 2028 as set forth below: 2. Mannatech shareholders voted to ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ended December 31, 2025 as set forth below: 3. Mannatech shareholders approved, on an advisory basis, the compensation of Mannatech's named executive officers as set forth below: 4. Mannatech shareholders approved, on an advisory basis, the frequency of future votes on compensation of Mannatech's named executive officers as set forth below: To begin improving your life and the lives of those around you, please visit About Mannatech Mannatech, Incorporated, is committed to transforming lives through the development, marketing, and sales of high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through its global network of independent associates and members. The company has been operating for more than 25 years of experience with operations in 25 markets^. For more information, visit ^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model. Please Note: This release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as 'may,' 'will,' 'should,' "hope," 'could,' 'would,' 'expects,' 'plans,' 'intends,' 'anticipates,' 'believes,' 'estimates,' 'approximates,' 'predicts,' 'projects,' 'potential,' and 'continues' or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Yahoo
05-06-2025
- Business
- Yahoo
Mannatech Announces Results of Annual Shareholders' Meeting
FLOWER MOUND, Texas, June 05, 2025--(BUSINESS WIRE)--Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech's annual shareholder meeting (the "Meeting") held Tuesday, June 3, 2025. Mannatech's Chairman of the Board, J. Stanley Fredrick, chaired the Meeting, and James Clavijo, Mannatech's Chief Financial Officer, spoke to the shareholders sharing the company's financial results for 2024. There were 1,900,930 outstanding shares of Mannatech's common stock as of April 8, 2025 entitled to vote and 1,478,342 shares, or approximately 77.8% represented at the Meeting, either in person or by proxy. The following matters were submitted and voted upon at the Meeting: 1. Mannatech shareholders voted on the election of two individuals to the Board of Directors as Class II Directors to hold office until 2028 as set forth below: Name Number of Shares For Number of Shares Withheld Broker Non-Votes J. Stanley Fredrick 996,410 59,239 422,693 Tyler J. Rameson 985,671 69,978 422,693 2. Mannatech shareholders voted to ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ended December 31, 2025 as set forth below: Number of Shares For Number of Shares Against Number of Shares Abstaining 1,423,478 53,835 1,029 3. Mannatech shareholders approved, on an advisory basis, the compensation of Mannatech's named executive officers as set forth below: Number of Shares For Number of Shares Against Number of Shares Abstaining Broker Non-Votes 1,039,986 8,620 7,043 422,693 4. Mannatech shareholders approved, on an advisory basis, the frequency of future votes on compensation of Mannatech's named executive officers as set forth below: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 774,408 619 280,406 216 422,693 To begin improving your life and the lives of those around you, please visit About Mannatech Mannatech, Incorporated, is committed to transforming lives through the development, marketing, and sales of high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through its global network of independent associates and members. The company has been operating for more than 25 years of experience with operations in 25 markets^. For more information, visit ^Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model. Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "may," "will," "should," "hope," "could," "would," "expects," "plans," "intends," "anticipates," "believes," "estimates," "approximates," "predicts," "projects," "potential," and "continues" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release. View source version on Contacts Investor Relations Contact Information: Erin K. BartaGeneral Counsel and Corporate Secretary972-471-7742ir@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
Mannatech Premieres Powerful New Documentary on Marathon Legend Steve Edwards
"The Long Run" showcases a world-record journey powered by Glycan Replenishment Therapy and unmatched determination. FLOWER MOUND, Texas, May 21, 2025--(BUSINESS WIRE)--Global health and wellness innovator Mannatech is proud to premiere Steve Edwards: The Long Run, an 11-minute short documentary chronicling the unbelievable true story of Steve Edwards—an everyday man turned endurance icon. With over 1,000 official marathons completed in record-setting average times, Edwards' legacy is one of resilience, quiet determination and the pursuit of human potential. The film debuts globally today, May 21, and is followed by an in-depth interview with Steve Edwards himself following the documentary. It is available to watch free at (registration required) and on the company's Facebook page, beginning at 7:30 p.m. CT. From a modest upbringing in Coventry, England, to three Guinness World Records and a final race that brought a crowd to tears, Steve's journey defies logic. Despite genetic challenges that made endurance athletics significantly harder, Steve pushed beyond the odds to set a new world record for running 1,000 official marathons in a faster average finish time than anyone else on the planet—averaging 3 hours, 21 minutes, and 47 seconds per race. Steve credits Mannatech's Glycan Replenishment Therapy with helping him recover faster, train harder and extend his running longevity well into his 60s.* "These products were a game-changer," he says in the documentary's companion interview. "Better recovery meant better training, and that meant better performance. The real impact showed up in my longevity—that's why I was able to go from 500 marathons to 1,000." *His daily regimen includes Ambrotose Life® powder and other foundational glycan-based supplements, which he says helped support his immune system and remain resilient across decades of high-level competition.* Landen Fredrick, CEO of Mannatech, shared the company's pride in presenting the story: "Steve's commitment to excellence—despite circumstances that would stop most people in their tracks—reflects the values we hold close at Mannatech. We're honored to have played even a small role in his journey and proud to bring this inspiring story to the world." Produced by acclaimed filmmaker Jim Fabio of True Blue Creative, The Long Run blends emotion, science and storytelling into a moving celebration of what's possible when nutrition, mindset and grit align. The premiere is followed by an exclusive interview where Steve breaks down his nutritional protocol, training mindset and the overlooked importance of glycans. Viewers can register now and watch the premiere at access is available to all. View source version on Contacts PR@ 1 (800) 281-4469 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
21-05-2025
- Business
- Business Wire
Mannatech Premieres Powerful New Documentary on Marathon Legend Steve Edwards
FLOWER MOUND, Texas--(BUSINESS WIRE)--Global health and wellness innovator Mannatech is proud to premiere Steve Edwards: The Long Run, an 11-minute short documentary chronicling the unbelievable true story of Steve Edwards—an everyday man turned endurance icon. With over 1,000 official marathons completed in record-setting average times, Edwards' legacy is one of resilience, quiet determination and the pursuit of human potential. The film debuts globally today, May 21, and is followed by an in-depth interview with Steve Edwards himself following the documentary. It is available to watch free at (registration required) and on the company's Facebook page, beginning at 7:30 p.m. CT. With over 1,000 official marathons completed in record-setting average times, Edwards' legacy is one of resilience, quiet determination and the pursuit of human potential. From a modest upbringing in Coventry, England, to three Guinness World Records and a final race that brought a crowd to tears, Steve's journey defies logic. Despite genetic challenges that made endurance athletics significantly harder, Steve pushed beyond the odds to set a new world record for running 1,000 official marathons in a faster average finish time than anyone else on the planet—averaging 3 hours, 21 minutes, and 47 seconds per race. Steve credits Mannatech's Glycan Replenishment Therapy with helping him recover faster, train harder and extend his running longevity well into his 60s.* 'These products were a game-changer,' he says in the documentary's companion interview. 'Better recovery meant better training, and that meant better performance. The real impact showed up in my longevity—that's why I was able to go from 500 marathons to 1,000.' * His daily regimen includes Ambrotose Life® powder and other foundational glycan-based supplements, which he says helped support his immune system and remain resilient across decades of high-level competition.* Landen Fredrick, CEO of Mannatech, shared the company's pride in presenting the story: 'Steve's commitment to excellence—despite circumstances that would stop most people in their tracks—reflects the values we hold close at Mannatech. We're honored to have played even a small role in his journey and proud to bring this inspiring story to the world.' Produced by acclaimed filmmaker Jim Fabio of True Blue Creative, The Long Run blends emotion, science and storytelling into a moving celebration of what's possible when nutrition, mindset and grit align. The premiere is followed by an exclusive interview where Steve breaks down his nutritional protocol, training mindset and the overlooked importance of glycans. Viewers can register now and watch the premiere at —complimentary access is available to all.
